Multiplex screening to detect uncommon and compound EGFR mutations

Uncommon and compound EGFR mutations are becoming increasingly relevant in understanding resistance to EGFR TKIs. In this DIALOG webinar, Adjunct Associate Professor Tony Lim (Singapore) shared the experience of Singapore General Hospital in detecting uncommon and compound mutations using multiplex screening.

About the speaker

Professor Tony Lim is a Senior Consultant and Head of Department of Anatomical Pathology, Singapore General Hospital and Section Head for Translational Pathology Centre, Department of Molecular Pathology. He is also Adjunct Associate Professor at Duke-NUS Graduate Medical School Singapore and School of Biological Sciences, Nanyang Technological University (NTU). He also holds the position of Vice Chair for Strategic Program in Pathology Academic Clinical Program (ACP), Clinical Core Faculty Member in Pathology Residency Program, SingHealth and Clinical Director of Personalized OMIC Lattice for Advanced Research and Improving Stratification (POLARIS)@GIS.

Estimated Time of Completion: 10 mins.